OHRP provides printable materials about participating in human research and clinical trials. Their new Checklist of Resources for Learning about Research and Research Participation provides…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
On May 19, 2022, the U.S. Food and Drug Administration (FDA) released new draft guidance for manufacturers and distributors of dietary supplements. The draft guidance,…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
Laser protective eyewear (LPE) is not one-size-fits all. It is also not one pair protects all. Appropriate LPE is an important component of every laser…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
As part of the push to implement the NIH Data Management and Sharing Policy on January 25, 2023, the NIH has released Informed Consent for…
FDA’s Center for Drug Evaluation and Research (CDER) has launched its new Accelerating Rare Disease Cures (ARC) Program to accelerate the development of safe and…
In December of 2021, the National Institutes of Health (NIH) released the ClinicalTrials.gov Beta to improve the interface and search functions as well as a…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
